The Mole Clinic Ltd Filleted accounts for Companies House (small and micro)

The Mole Clinic Ltd Filleted accounts for Companies House (small and micro)


false false false false false false false false false true false false false false false false false No description of principal activity 2019-01-01 Sage Accounts Production Advanced 2018 Update 1 - FRS 15,699 15,698 1 1 xbrli:pure xbrli:shares iso4217:GBP 04903102 2019-01-01 2019-12-31 04903102 2019-12-31 04903102 2018-12-31 04903102 2018-01-01 2018-12-31 04903102 2018-12-31 04903102 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2019-01-01 2019-12-31 04903102 core:FurnitureFittings 2019-01-01 2019-12-31 04903102 bus:LeadAgentIfApplicable 2019-01-01 2019-12-31 04903102 bus:Director4 2019-01-01 2019-12-31 04903102 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2019-12-31 04903102 core:LandBuildings 2018-12-31 04903102 core:FurnitureFittings 2018-12-31 04903102 core:LandBuildings 2019-12-31 04903102 core:FurnitureFittings 2019-12-31 04903102 core:LandBuildings 2019-01-01 2019-12-31 04903102 core:WithinOneYear 2019-12-31 04903102 core:WithinOneYear 2018-12-31 04903102 core:ShareCapital 2019-12-31 04903102 core:ShareCapital 2018-12-31 04903102 core:SharePremium 2019-12-31 04903102 core:SharePremium 2018-12-31 04903102 core:RetainedEarningsAccumulatedLosses 2019-12-31 04903102 core:RetainedEarningsAccumulatedLosses 2018-12-31 04903102 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2018-12-31 04903102 core:LandBuildings 2018-12-31 04903102 core:FurnitureFittings 2018-12-31 04903102 bus:SmallEntities 2019-01-01 2019-12-31 04903102 bus:AuditExemptWithAccountantsReport 2019-01-01 2019-12-31 04903102 bus:FullAccounts 2019-01-01 2019-12-31 04903102 bus:SmallCompaniesRegimeForAccounts 2019-01-01 2019-12-31 04903102 bus:PrivateLimitedCompanyLtd 2019-01-01 2019-12-31 04903102 core:LandBuildings core:LongLeaseholdAssets 2019-01-01 2019-12-31 04903102 core:ComputerEquipment 2019-01-01 2019-12-31 04903102 core:ComputerEquipment 2018-12-31 04903102 core:ComputerEquipment 2019-12-31
COMPANY REGISTRATION NUMBER: 04903102
The Mole Clinic Ltd
Filleted Unaudited Financial Statements
31 December 2019
The Mole Clinic Ltd
Financial Statements
Year ended 31 December 2019
Contents
Page
Chartered accountant's report to the board of directors on the preparation of the unaudited statutory financial statements
1
Statement of financial position
2
Notes to the financial statements
4
The Mole Clinic Ltd
Chartered Accountant's Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of The Mole Clinic Ltd
Year ended 31 December 2019
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of The Mole Clinic Ltd for the year ended 31 December 2019, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/membership/regulations-standards-and-guidance. This report is made solely to the Board of Directors of The Mole Clinic Ltd, as a body, in accordance with the terms of our engagement letter dated 3 December 2013. Our work has been undertaken solely to prepare for your approval the financial statements of The Mole Clinic Ltd and state those matters that we have agreed to state to you, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF as detailed at www.icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than The Mole Clinic Ltd and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that The Mole Clinic Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of The Mole Clinic Ltd. You consider that The Mole Clinic Ltd is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of The Mole Clinic Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
THE COOK PARTNERSHIP Chartered accountants
Unit 7 The Forum Icknield Way Tring Hertfordshire HP23 4JY
21 July 2020
The Mole Clinic Ltd
Statement of Financial Position
31 December 2019
2019
2018
Note
£
£
£
Fixed assets
Intangible assets
5
1
1
Tangible assets
6
425,509
152,877
---------
---------
425,510
152,878
Current assets
Debtors
7
257,553
159,611
Cash at bank and in hand
729,862
561,169
---------
---------
987,415
720,780
Creditors: amounts falling due within one year
8
213,014
188,344
---------
---------
Net current assets
774,401
532,436
------------
---------
Total assets less current liabilities
1,199,911
685,314
Provisions
58,542
17,270
------------
---------
Net assets
1,141,369
668,044
------------
---------
The Mole Clinic Ltd
Statement of Financial Position (continued)
31 December 2019
2019
2018
Note
£
£
£
Capital and reserves
Called up share capital
1,212
1,212
Share premium account
294,738
294,738
Profit and loss account
845,419
372,094
------------
---------
Shareholders funds
1,141,369
668,044
------------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 31 December 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 21 July 2020 , and are signed on behalf of the board by:
Mr I D Mack
Director
Company registration number: 04903102
The Mole Clinic Ltd
Notes to the Financial Statements
Year ended 31 December 2019
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 46 Harley Street, London, W1G 9PT, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more, or a right to pay less or to receive more tax, with the following exceptions: deferred tax is not provided on timing differences arising from the revaluation of fixed assets where there is no commitment to sell that asset. deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted. Deferred tax is measured on a discounted/an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are recorded at the fair value at the acquisition date.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Trademarks
-
33% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Leasehold property
-
Straight line over 10 years
Fixtures & Fittings
-
25% straight line
Equipment
-
25% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 21 (2018: 17 ).
5. Intangible assets
Development costs
£
Cost
At 1 January 2019 and 31 December 2019
15,699
--------
Amortisation
At 1 January 2019 and 31 December 2019
15,698
--------
Carrying amount
At 31 December 2019
1
--------
At 31 December 2018
1
--------
6. Tangible assets
Land and buildings
Fixtures and fittings
Equipment
Total
£
£
£
£
Cost
At 1 January 2019
149,189
19,154
102,832
271,175
Additions
253,417
11,296
63,769
328,482
Disposals
( 4,181)
( 4,181)
---------
--------
---------
---------
At 31 December 2019
402,606
30,450
162,420
595,476
---------
--------
---------
---------
Depreciation
At 1 January 2019
36,214
11,800
70,284
118,298
Charge for the year
21,479
5,003
25,929
52,411
Disposals
( 742)
( 742)
---------
--------
---------
---------
At 31 December 2019
57,693
16,803
95,471
169,967
---------
--------
---------
---------
Carrying amount
At 31 December 2019
344,913
13,647
66,949
425,509
---------
--------
---------
---------
At 31 December 2018
112,975
7,354
32,548
152,877
---------
--------
---------
---------
7. Debtors
2019
2018
£
£
Trade debtors
103,862
68,233
Other debtors
153,691
91,378
---------
---------
257,553
159,611
---------
---------
8. Creditors: amounts falling due within one year
2019
2018
£
£
Trade creditors
75,318
75,866
Corporation tax
88,131
76,523
Social security and other taxes
31,331
26,093
Pension
7,438
1,602
Other creditors
10,796
8,260
---------
---------
213,014
188,344
---------
---------
9. Controlling party
The company was under the control of Iain Mack, a director.